miR‐522 has also been reported to be able to boost colorectal tumorigenesis via targeting BLM [25], accelerate the progression of endometrial carcinoma by inhibiting MAOB [29], as well as promote glioblastoma cell proliferation by suppressing PHLPP1 [26]. This evidence concerns the gene MAOB and endometrial carcinoma.